Biden Accuser Flores: Inappropriate Treatment of Women

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
104
Biden Accuser Flores:
Inappropriate Treatment of Women
‘Disqualifying’ for 2020 Run < >

Sunday on CNN’s “The Lead,” former Nevada lawmaker Lucy Flores, who has accused former Vice President Joe Biden of inappropriately touching and kissing her in 2014, said Biden’s treatment of woman was “disqualifying” as a presidential candidate.

Flores said, “My point was never about his intentions, and they shouldn’t be about his intentions. It should be about the women on the receiving end of that behavior. This isn’t the first time, and it wasn’t the only incident where he was acting inappropriately with women. If he is saying he never believed that was inappropriate, then frankly I think that’s a little bit of a disconnect, and not being aware, a sense of not being aware because there has been documentation both in photos, videos, stories that were written. Now, that being said, I think part of the reason I decided to finally say something is because those behaviors were not being taken very seriously. They were not being considered from the perspective of the woman on the other side of that power dynamic, on the side, on the receiving end. I just can’t imagine that there was never a situation where someone said to him, Mr. Vice President, you probably should stop doing that. You should probably stop touching women in that way. You should probably keep your hands to yourself.”

She continued, “I would say politics was definitely the impetus. I he reason we’re having these conversations about Vice President Joe Biden is because he’s considering running for president. Frankly, the reason why I felt so compelled to finally say something was because over the years as this behavior was documented as it was frankly dismissed by the media and not taken seriously, that conversation was not coming up in the discussions about whether or not he would in a complete analysis of his history, of his record, as we go through the vetting process for all of these candidates, that important aspect was being left out. It was being dismissed, and it wasn’t being acknowledged. For me, that was one incredibly offensive and, two, speaks to the fact that when behavior isn’t considered, quote, unquote, serious enough for society, for America, it’s very easy to dismiss it.”

She added, “For me, it’s disqualifying. I think it’s up to everybody else to make that decision, considering, again, the entire scope of his background, of the positions that he’s taken. For me this isn’t the only problematic thing, I think his response in the way in which he handled the Anita Hill hearing was completely inappropriate and lacked empathy and frankly lacked accountability, saying he wishes there was something more he could have done. I think it’s again, a complete lack of accountability. You were the chair, you were the chair of that hearing, and you could have done anything you wanted. In addition to previous anti-abortion positions that he’s taken, et cetera, I find a lot of his background problematic.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles